Drugs-of-Abuse Testing/Programs

Test for 10 drugs with one sample

RandoxFor use on this company’s RX series of clinical-chemistry analyzers, the drugs-of-abuse (DOA) arrays use biochip array technology to simultaneously detect 10 DOA in a single sample. Each biochip contains an array of 10 discrete test regions of immobilized antibodies specific to different drugs. Tests can be run on human urine or whole blood. The array requires a very small sample volume to test for the following DOA: cannabinoids, cocaine metabolite, EDDP, ecstasy, methadone, opiates, amphetamines, barbiturates, benzodiazepines, and ethanol. These tests are suited for use in police/crime, hospital, prison, and private screening laboratories.

Randox

Visit www.rsleads.com/909ml-151


Improve DOA workflow

The EasyTox 2.5 GX/MS is a productivity solution software package for routine drugs-of-abuse (DOA) analysis. This platform has been designed to reduce costs, increase sample throughput, and improve productivity. This software includes complete methods and documentation for extraction and GC/MS analysis of common DOA in urine, offering full compliance to SAMHSA requirements for DOA testing. New DuraBrite XL ion source revolutionizes MS maintenance. ToxLab Forms 2.5 software includes Method Forge, an automated method builder, designed to reduce method-development time, optimize efficiency, and simplify day-to-day sample analysis.

Thermo Fisher Scientific

Visit www.rsleads.com/903ml-152


 

 

 

ACM Global Central Lab and BioClinica Discuss How Central Lab and EDC ... - MarketWatch (press release)

Trinity Biotech Announces Quarter 4 Financial Results EPS Increases From 7.1 ... - CNNMoney.com (press release)

Antibody validation - BioTechniques.com

Safeguard Scientifics Announces Fourth Quarter and Year-End 2009 Financial Results - MarketWatch (press release)

Vermillion Announces Scientific Advisory Board Appointments - PR Newswire (press release)

CombiMatrix Corporation Reports Fourth Quarter 2009 Financial Results - Lifescience-online

NeoMed Takes a 6.3% Investment in CytoCore Inc. - MarketWatch (press release)

Enoxaparin Anticoagulation Monitoring in the Catheterization Laboratory Using ... - Cardiosource

Vitamin D shows promise; research still lagging - Chicago Tribune (blog)

Proteonomix, Inc. Announces the Formation of PRTMI RD SRL as a PRTMI Subsidiary - CNNMoney.com (press release)

 

 

Search more than 3,500 tests, equipment, products, and services for the clinical lab market with company cross references